These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 26652621

  • 1. Role of pressure-sensitive adhesives in transdermal drug delivery systems.
    Lobo S, Sachdeva S, Goswami T.
    Ther Deliv; 2016; 7(1):33-48. PubMed ID: 26652621
    [Abstract] [Full Text] [Related]

  • 2. The role of carboxyl group of pressure sensitive adhesive in controlled release of propranolol in transdermal patch: Quantitative determination of ionic interaction and molecular mechanism characterization.
    Yang D, Wan X, Quan P, Liu C, Fang L.
    Eur J Pharm Sci; 2018 Mar 30; 115():330-338. PubMed ID: 29414309
    [Abstract] [Full Text] [Related]

  • 3. Approaches for breaking the barriers of drug permeation through transdermal drug delivery.
    Alexander A, Dwivedi S, Ajazuddin, Giri TK, Saraf S, Saraf S, Tripathi DK.
    J Control Release; 2012 Nov 28; 164(1):26-40. PubMed ID: 23064010
    [Abstract] [Full Text] [Related]

  • 4. A systemic evaluation of drug in acrylic pressure sensitive adhesive patch in vitro and in vivo: The roles of intermolecular interaction and adhesive mobility variation in drug controlled release.
    Liu C, Quan P, Li S, Zhao Y, Fang L.
    J Control Release; 2017 Apr 28; 252():83-94. PubMed ID: 28274741
    [Abstract] [Full Text] [Related]

  • 5. A novel transdermal drug delivery system based on self-adhesive Janus nanofibrous film with high breathability and monodirectional water-penetration.
    Shi Y, Li Y, Wu J, Wang W, Dong A, Zhang J.
    J Biomater Sci Polym Ed; 2014 Apr 28; 25(7):713-28. PubMed ID: 24641249
    [Abstract] [Full Text] [Related]

  • 6. Chemistry, manufacturing and controls in passive transdermal drug delivery systems.
    Goswami T, Audett J.
    Ther Deliv; 2015 Apr 28; 6(9):1071-9. PubMed ID: 26389777
    [Abstract] [Full Text] [Related]

  • 7. Recent advances in transdermal drug delivery.
    Subedi RK, Oh SY, Chun MK, Choi HK.
    Arch Pharm Res; 2010 Mar 28; 33(3):339-51. PubMed ID: 20361297
    [Abstract] [Full Text] [Related]

  • 8. Development and evaluation of a drug-in-adhesive transdermal delivery system for delivery of olanzapine.
    Vora D, Banga AK.
    Expert Opin Drug Deliv; 2022 Nov 28; 19(11):1539-1548. PubMed ID: 36242524
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
    Wokovich AM, Prodduturi S, Doub WH, Hussain AS, Buhse LF.
    Eur J Pharm Biopharm; 2006 Aug 28; 64(1):1-8. PubMed ID: 16797171
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of formulation variables in transdermal drug delivery system containing zolmitriptan.
    Subedi RK, Ryoo JP, Moon C, Choi HK.
    Int J Pharm; 2011 Oct 31; 419(1-2):209-14. PubMed ID: 21843607
    [Abstract] [Full Text] [Related]

  • 13. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
    Soler LI, Boix A, Lauroba J, Colom H, Domenech J.
    Drug Dev Ind Pharm; 2012 Oct 31; 38(10):1171-8. PubMed ID: 22204649
    [Abstract] [Full Text] [Related]

  • 14. Water-compatible cross-linked pyrrolidone acrylate pressure-sensitive adhesives with persistent adhesion for transdermal delivery: Synergistic effect of hydrogen bonding and electrostatic force.
    Gong K, Sun P, Cai Y, Wang X, Pang Y, Liu C, Guo J, Fang L.
    Acta Biomater; 2024 Apr 15; 179():130-148. PubMed ID: 38460932
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
    Roy SD, Gutierrez M, Flynn GL, Cleary GW.
    J Pharm Sci; 1996 May 15; 85(5):491-5. PubMed ID: 8742940
    [Abstract] [Full Text] [Related]

  • 17. Chemical penetration enhancers.
    Newton SJ.
    Int J Pharm Compd; 2013 May 15; 17(5):370-4. PubMed ID: 24459781
    [Abstract] [Full Text] [Related]

  • 18. Adhesive properties: a critical issue in transdermal patch development.
    Cilurzo F, Gennari CG, Minghetti P.
    Expert Opin Drug Deliv; 2012 Jan 15; 9(1):33-45. PubMed ID: 22171789
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development of transdermal therapeutic formulation of CNS5161, a novel NMDA receptor antagonist, by utilizing pressure-sensitive adhesives II: improved transdermal absorption and evaluation of efficacy and safety.
    Naruse M, Ogawara K, Kimura T, Konishi R, Higaki K.
    Eur J Pharm Sci; 2014 Feb 14; 52():86-94. PubMed ID: 24215737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.